HB572 (2021) Detail

Relative to pharmacist administration of vaccines and allowing a licensed advanced pharmacy technician to administer vaccines.


HB 572 - VERSION ADOPTED BY BOTH BODIES

 

7Apr2021... 0576h

05/20/2021   1464s

2021 SESSION

21-0708

10/08

 

HOUSE BILL 572

 

AN ACT relative to pharmacist administration of vaccines and allowing a licensed advanced pharmacy technician to administer vaccines.

 

SPONSORS: Rep. Merchant, Sull. 4; Sen. Prentiss, Dist 5

 

COMMITTEE: Health, Human Services and Elderly Affairs

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill allows licensed advanced pharmacy technicians to administer vaccines, combines the pharmacist administration of vaccines authority into one section, provides for recording vaccinations in the state vaccine registry, and requires the report of any adverse reactions.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

7Apr2021... 0576h

05/20/2021   1464s 21-0708

10/08

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty One

 

AN ACT relative to pharmacist administration of vaccines and allowing a licensed advanced pharmacy technician to administer vaccines.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Pharmacist Administration of Vaccines.  RSA 318:16-b is repealed and reenacted to read as follows:

318:16-b  Pharmacist Administration of Vaccines.  A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer influenza and a COVID-19 vaccine, if available, to the general public.  A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer haemophilus influenza, hepatitis A, hepatitis B, hepatitis A and B, human papillomavirus, meningococcal, pneumococcal, tetanus and diphtheria, varicella, zoster, MMR (measles, mumps, and rubella), and Tdap (tetanus, diphtheria and pertussis) vaccines, which have been approved by the Food and Drug Administration, to individuals 18 years of age or older as ordered by an immunizing pharmacist.  The pharmacist, pharmacy intern, or licensed advanced pharmacy technician shall:

I. Hold a current license to practice as a pharmacist, be registered as a pharmacy intern under RSA 318:15-b in New Hampshire, or be licensed as a licensed advanced pharmacy technician under RSA 318:15-c.

II. Possess at least $1,000,000 of professional liability insurance coverage.

III. In order to administer vaccines, have completed training specific to administration of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board.

IV. Provide to the board evidence of compliance with paragraphs I-III.

V.  Provide notice to the primary care provider, when designated by the patient, of the administration of any vaccine.

VI. Record the vaccination in the state vaccine registry in accordance with RSA 141-C:20-f and/or when required by state and federal law and maintain a record of the vaccination as required by state and federal law.

VII.  Submit reports of any adverse reactions following vaccination to the Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System (VAERS).

2 Repeal.  RSA 318:16-d, relative to additional authority for pharmacist administration of vaccines, is repealed.

3  Effective Date.  This act shall take effect 90 days upon passage.

Links

HB572 at GenCourtMobile
HB572 Discussion

Action Dates

Date Body Type
Feb. 16, 2021 House Hearing
March 2, 2021 House Exec Session
House Floor Vote
April 28, 2021 Senate Hearing
May 20, 2021 Senate Floor Vote

Bill Text Revisions

HB572 Revision: 32678 Date: June 10, 2021, 11:50 a.m.
HB572 Revision: 32505 Date: May 20, 2021, 10:27 a.m.
HB572 Revision: 32279 Date: April 7, 2021, 10:49 a.m.
HB572 Revision: 31891 Date: Jan. 12, 2021, 1:23 p.m.

Docket


June 10, 2021: House Concurs with Senate Amendment 2021-1464s (Rep. M. Pearson): MA VV 06/10/2021


May 20, 2021: Ought to Pass with Amendment 2021-1464s, MA, VV; OT3rdg; 05/20/2021; SJ 16


May 20, 2021: Committee Amendment # 2021-1464s, AA, VV; 05/20/2021; SJ 16


May 20, 2021: Committee Report: Ought to Pass with Amendment # 2021-1464s, 05/20/2021; Vote 5-0; CC; SC 24


April 28, 2021: Remote Hearing: 04/28/2021, 09:15 am; Links to join the hearing can be found in the Senate Calendar; SC 21


April 1, 2021: Introduced 04/01/2021 and Referred to Health and Human Services; SJ 11


April 7, 2021: Reconsider (Rep. Osborne): MF VV 04/07/2021 HJ 5 P. 50


April 7, 2021: Ought to Pass with Amendment 2021-0576h: MA VV 04/07/2021 HJ 5 P. 35


April 7, 2021: Amendment # 2021-0576h: AA VV 04/07/2021 HJ 5 P. 35


: Committee Report: Ought to Pass with Amendment # 2021-0576h (Vote 19-0; CC) HC 18 P. 16


March 2, 2021: Executive Session: 03/02/2021 12:30 pm Members of the public may attend using the following links: To join the webinar: https://www.zoom.us/j/99282187833


Feb. 16, 2021: Public Hearing: 02/16/2021 09:00 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/94563888809 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened.


Jan. 6, 2021: Introduced (in recess of) 01/06/2021 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 54